Statistical harmonization can improve the development of a multicenter CT-based radiomic model predictive of nonresponse to induction chemotherapy in laryngeal cancers.

CT ComBat imaging biomarkers and radiomics larynx cancer prediction of treatment response unsupervised learning

Journal

Medical physics
ISSN: 2473-4209
Titre abrégé: Med Phys
Pays: United States
ID NLM: 0425746

Informations de publication

Date de publication:
Jul 2021
Historique:
revised: 18 04 2021
received: 25 09 2020
accepted: 06 05 2021
pubmed: 20 5 2021
medline: 30 7 2021
entrez: 19 5 2021
Statut: ppublish

Résumé

To develop a radiomic model predicting nonresponse to induction chemotherapy in laryngeal cancers, from multicenter pretherapeutic contrast-enhanced computed tomography (CE-CT) and evaluate the benefit of feature harmonization in such a context. Patients (n = 104) eligible for laryngeal preservation chemotherapy were included in five centers. Primary tumor was manually delineated on the CE-CT images. The following radiomic features were extracted with an in-house software (MIRAS v1.1, LaTIM UMR 1101): intensity, shape, and textural features derived from Gray-Level Co-occurrence Matrix (GLCM), Neighborhood Gray Tone Difference Matrix (NGTDM), Gray-Level Run Length Matrix (GLRLM), and Gray-Level Size Zone Matrix (GLSZM). Harmonization was performed using ComBat after unsupervised hierarchical clustering, used to determine labels automatically, given the high heterogeneity of imaging characteristics across and within centers. Patients with similar feature distributions were grouped with unsupervised clustering into an optimal number of clusters (2) determined with "silhouette scoring." Statistical harmonization was then carried out with ComBat on these 2 identified clusters. The cohort was split into training/validation (n = 66) and testing (n = 32) sets. Area under the receiver operating characteristics curves (AUC) were used to evaluate the ability of radiomic features (before and after harmonization) to predict nonresponse to chemotherapy, and specificity (Sp) and sensitivity (Se) were used to quantify their performance in the testing set. Without harmonization, none of the features identified as predictive in the training set remained significant in the testing set. After ComBat, one textural feature identified in the training set keeps a predictive trend in the testing set-Zone Percentage, derived from the GLSZM, was predictive of nonresponse in the training set (AUC = 0.62, Se = 70%, Sp = 64%, P = 0.04) and obtained a satisfactory performance in the testing set (Se = 80%, Sp = 67%, P = 0.03), although significance was limited by the size of the testing set. These results are consistent with previously published findings in head and neck cancers. Radiomic features from CE-CT could help in the selection of patients for induction chemotherapy in laryngeal cancers, with relatively good sensitivity and specificity in predicting lack of response. Statistical harmonization with ComBat and unsupervised clustering seems to improve the predictive value of features extracted in such a heterogeneous multicenter setting.

Identifiants

pubmed: 34008178
doi: 10.1002/mp.14948
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

4099-4109

Subventions

Organisme : Fondation pour la Recherche Médicale (FRM)
ID : M2R201806006004
Organisme : Foundation for Medical Research (FRM)
ID : M2R201806006004

Informations de copyright

© 2021 American Association of Physicists in Medicine.

Références

John Andrew Ridge MD. Head and Neck Tumors. Cancer Network. Published June 2, 2016. Accessed August 5, 2019. https://www.cancernetwork.com/cancer-management/head-and-neck-tumors.
Pointreau Y, Garaud P, Chapet S, et␣al. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst. 2009;101:498-506.
Forastiere AA, Goepfert H, Maor M, et␣al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091-2098.
Department of Veterans Affairs Laryngeal Cancer Study Group. Wolf GT, Fisher SG, et␣al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324:1685-1690.
Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst. 1996;88:890-899.
Shafiq-ul-Hassan M, Zhang GG, Latifi K, et␣al. Intrinsic dependencies of CT radiomic features on voxel size and number of gray levels. Med Phys. 2017;44:1050-1062.
Berenguer R, Pastor-Juan MDR, Canales-Vázquez J, et␣al. Radiomics of CT features may be nonreproducible and redundant: influence of CT acquisition parameters. Radiology. 2018;288:407-415.
Espinasse M, Pitre-Champagnat S, Charmettant B, et␣al. CT texture analysis challenges: influence of acquisition and reconstruction parameters: a comprehensive review. Diagnostics. 2020;10:258.
Kim H, Park CM, Lee M, et␣al. Impact of reconstruction algorithms on CT radiomic features of pulmonary tumors: analysis of intra- and inter-reader variability and inter-reconstruction algorithm variability. PLoS One. 2016;11.e0164924
Zwanenburg A, Leger S, Vallières M, Löck S. Image biomarker standardisation initiative. arXiv:161207003 [cs]. Published online December 21, 2016. Accessed April 1, 2019. http://arxiv.org/abs/1612.07003.
Desseroit MC, Tixier F, Cheze Le Rest C. Comparison of three quantization methods for the calculation of textural features in PET/CT images: impact on prognostic models in non-small cell lung cancer. In: IEEE NSS-MIC; 2016.
Leijenaar RTH, Nalbantov G, Carvalho S, et␣al. The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis. Sci Rep. 2015;5:11075.
Leijenaar RTH, Bogowicz M, Jochems A, et␣al. Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study. BJR. 2018;91:20170498.
Bogowicz M, Riesterer O, Bundschuh RA, et␣al. Stability of radiomic features in CT perfusion maps. Phys Med Biol. 2016;61:8736-8749.
Lucia F, Visvikis D, Desseroit M-C, et␣al. Prediction of outcome using pretreatment 18F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy. Eur J Nucl Med Mol Imaging. 2018;45:768-786. Published online December 9, 2017.
Vallières M, Freeman CR, Skamene SR, El Naqa I. A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities. Phys Med Biol. 2015;60:5471-5496.
Vallières M, Kay-Rivest E, Perrin LJ, et␣al. Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer. Sci Rep. 2017;7.
Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118-127.
Orlhac F, Frouin F, Nioche C, Ayache N, Buvat I. Validation of a method to compensate multicenter effects affecting CT radiomics. Radiology. 2019;291:53-59.
Lucia F, Visvikis D, Vallières M, et␣al. External validation of a combined PET and MRI radiomics model for prediction of recurrence in cervical cancer patients treated with chemoradiotherapy. Eur J Nucl Med Mol Imaging. 2019;46:864-877. Published online December 7, 2018.
Orlhac F, Boughdad S, Philippe C, et␣al. A postreconstruction harmonization method for multicenter radiomic studies in PET. J Nucl Med. 2018;59:1321-1328.
Murtagh F, Contreras P. Methods of Hierarchical Clustering. arXiv:11050121 [cs, math, stat]. Published online April 30, 2011. Accessed September 5, 2019. http://arxiv.org/abs/1105.0121.
Rousseeuw PJ. Silhouettes: a graphical aid to the interpretation and validation of cluster analysis. J Comput Appl Math. 1987;20:53-65.
Da-ano R, Masson I, Lucia F, et␣al. Performance comparison of modified ComBat for harmonization of radiomic features for multicenter studies. Sci Rep. 2020;10:10248.
Vallieres M, Zwanenburg A, Badic B, Cheze-Le Rest C, Visvikis D, Hatt M. Responsible radiomics research for faster clinical translation. J Nucl Med. 2018;59:189-193. Published online November 24, 2017.
Forastiere AA, Weber RS, Trotti A. Organ preservation for advanced larynx cancer: issues and outcomes. J Clin Oncol. 2015;33:3262-3268.
Forastiere AA, Ismaila N, Lewin JS, et␣al. Use of larynx-preservation strategies in the treatment of laryngeal cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2018;36:1143-1169.
Patel UA, Howell LK. Local response to chemoradiation in T4 larynx cancer with cartilage invasion. The Laryngoscope. 2011;121:106-110.
Meyer M, Ronald J, Vernuccio F, et␣al. Reproducibility of CT radiomic features within the same patient: influence of radiation dose and CT reconstruction settings. Radiology. 2019;293:583-591.
Bogowicz M, Riesterer O, Ikenberg K, et␣al. Computed tomography radiomics predicts HPV status and local tumor control after definitive radiochemotherapy in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2017;99:921-928.
Caudell JJ, Torres-Roca JF, Gillies RJ, et␣al. The future of personalised radiotherapy for head and neck cancer. Lancet Oncol. 2017;18:e266-e273.
Bogowicz M, Tanadini-Lang S, Veit-Haibach P, et␣al. Perfusion CT radiomics as potential prognostic biomarker in head and neck squamous cell carcinoma. Acta Oncol. 2019;1-5.
Yip SS, Aerts HJWL. Applications and limitations of radiomics. Phys Med Biol. 2016;61:R150-R166.
Lovinfosse P, Visvikis D, Hustinx R, Hatt M. FDG PET radiomics: a review of the methodological aspects. Clin Transl Imaging. 2018;6:379-391.
Aerts HJWL, Velazquez ER, Leijenaar RTH, et␣al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006.
Larue RTHM, Defraene G, De Ruysscher D, Lambin P, van Elmpt W. Quantitative radiomics studies for tissue characterization: a review of technology and methodological procedures. BJR. 2016;90:20160665.
Hermans R, Feron M, Bellon E, Dupont P, den Bogaert WV, Baert AL. Laryngeal tumor volume measurements determined with CT: a study on intra- and interobserver variability. Int J Radiat Oncol Biol Phys. 1998;40:553-557.
Leijenaar RTH, Carvalho S, Hoebers FJP, et␣al. External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma. Acta Oncol. 2015;54:1423-1429.
Bagher-Ebadian H, Siddiqui F, Liu C, Movsas B, Chetty IJ. On the impact of smoothing and noise on robustness of CT and CBCT radiomics features for patients with head and neck cancers. Med Phys. 2017;44:1755-1770.
Bogowicz M, Riesterer O, Stark LS, et␣al. Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma. Acta Oncol. 2017;56:1531-1536.
Geets X, Daisne J-F, Arcangeli S, et␣al. Inter-observer variability in the delineation of pharyngo-laryngeal tumor, parotid glands and cervical spinal cord: comparison between CT-scan and MRI. Radiother Oncol. 2005;77:25-31.
Pavic M, Bogowicz M, Würms X, et␣al. Influence of inter-observer delineation variability on radiomics stability in different tumor sites. Acta Oncol. 2018;57:1070-1074.
Reuzé S, Orlhac F, Chargari C, et␣al. Prediction of cervical cancer recurrence using textural features extracted from 18 F-FDG PET images acquired with different scanners. Oncotarget. 2017;8:43169-43179.
Goh WWB, Wang W, Wong L. Why batch effects matter in omics data, and how to avoid them. Trends Biotechnol. 2017;35:498-507.

Auteurs

Ingrid Masson (I)

LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.

Ronrick Da-Ano (R)

LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.

François Lucia (F)

LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.
Radiation Oncology Department, University Hospital, Brest, France.

Mélanie Doré (M)

Department of Radiation Oncology, Institut de cancérologie de l'Ouest René-Gauducheau, Saint-Herblain, France.

Joel Castelli (J)

Radiotherapy Department Cancer, Institute Eugène Marquis, Rennes, France.
University of Rennes 1, LTSI, Rennes, France.

Camille Goislard de Monsabert (C)

Radiotherapy Department Cancer, Institute Eugène Marquis, Rennes, France.

Jean-François Ramée (JF)

Department of Medical Oncology, Centre Hospitalier de Vendée, La Roche sur Yon, France.

Selima Sellami (S)

Radiation Oncology Department, University Hospital, Brest, France.
Radiotherapy Department, Centre Hospitalier de Cornouaille, Quimper, France.

Dimitris Visvikis (D)

LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.

Mathieu Hatt (M)

LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.

Ulrike Schick (U)

LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.
Radiation Oncology Department, University Hospital, Brest, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH